7-Gene Predictive Biosignature Helps Predict Ipsilateral Breast Cancer Recurrence
Patients with breast cancer who have a high-risk clinicopathology but a low 10-year risk of ipsilateral breast recurrence (IBR) risk, determined via a 7-gene predictive biosignature, were not found to have a significant benefit from radiation therapy (RT), …